Top compounds associated with response to NAT14


Feature Type Standardized
Nominal ANOVA
mRNA dabrafenib CTRPv2 pan-cancer AAC 0.13 0.01
mRNA GSK1059615 CTRPv2 pan-cancer AAC 0.12 0.01
mRNA necrosulfonamide CTRPv2 pan-cancer AAC 0.098 0.01
mRNA (5Z)-7-Oxozeaenol GDSC1000 pan-cancer AAC 0.08 0.01
mRNA ISOX CTRPv2 pan-cancer AAC 0.08 0.01
mRNA decitabine:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.078 0.02
mRNA CAY10618 CTRPv2 pan-cancer AAC 0.088 0.02
mRNA navitoclax:sorafenib (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.087 0.02
mRNA Nilotinib GDSC1000 pan-cancer AAC 0.092 0.02
mRNA SB-225002 CTRPv2 pan-cancer AAC 0.074 0.02
Download CSV